Denali Therapeutics Inc. (DNLI) PT Lowered to $36 at Goldman Sachs, Following Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: DNLI) | Delayed: 21.31 +1.86 (9.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.45 | 52 Week High | $ | |||
| Open | $21.23 | 52 Week Low | $ | |||
| Day High | $22.19 | P/E | N/A | |||
| Day Low | $19.75 | EPS | $ | |||
| Volume | 2,676,506 | |||||
